<DOC>
	<DOCNO>NCT00404703</DOCNO>
	<brief_summary>This single arm study ass feasibility use Avastin plus platinum-based chemotherapy ( cisplatin-gemcitabine carboplatin-paclitaxel ) patient advanced recurrent squamous non-small cell lung cancer receive prior chemotherapy . Patients receive preventive radiation , follow one cycle chemotherapy alone 5 cycle chemotherapy combination Avastin ( 15mg/kg iv day 1 3 weekly cycle ) , follow Avastin alone maximum total treatment period Avastin 12 month . The anticipated time study treatment 3-12 month , target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Study Avastin ( Bevacizumab ) Combination With Platinum-Based Chemotherapy Patients With Advanced Recurrent Squamous Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>adult patient , &gt; =18 year age ; document squamous nonsmall cell lung cancer ; stage IIIb pleural pericardial effusion , stage IV , recurrent disease ; suitable platinumbased treatment first line chemotherapy . prior systemic antitumor therapy ; prior radiotherapy treatment patient 's current stage disease ; primary tumor within last 5 year , except control limited basal cell squamous cancer skin , cancer situ cervix ; major surgery , open biopsy significant traumatic injury within 28 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>